ZA9410189B - Novel stem cell factor formulations and methods - Google Patents

Novel stem cell factor formulations and methods

Info

Publication number
ZA9410189B
ZA9410189B ZA9410189A ZA9410189A ZA9410189B ZA 9410189 B ZA9410189 B ZA 9410189B ZA 9410189 A ZA9410189 A ZA 9410189A ZA 9410189 A ZA9410189 A ZA 9410189A ZA 9410189 B ZA9410189 B ZA 9410189B
Authority
ZA
South Africa
Prior art keywords
stem cell
cell factor
methods
novel stem
factor formulations
Prior art date
Application number
ZA9410189A
Other languages
English (en)
Inventor
Susan I Hershenson
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of ZA9410189B publication Critical patent/ZA9410189B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9410189A 1993-12-22 1994-12-21 Novel stem cell factor formulations and methods ZA9410189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/172,507 US6288030B1 (en) 1993-12-22 1993-12-22 Stem cell factor formulations and methods

Publications (1)

Publication Number Publication Date
ZA9410189B true ZA9410189B (en) 1995-08-25

Family

ID=22627993

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9410189A ZA9410189B (en) 1993-12-22 1994-12-21 Novel stem cell factor formulations and methods

Country Status (14)

Country Link
US (4) US6288030B1 (da)
EP (1) EP0732935B1 (da)
CN (1) CN1105575C (da)
AT (1) ATE173402T1 (da)
AU (1) AU696860B2 (da)
CA (1) CA2182970C (da)
DE (1) DE69414723T2 (da)
DK (1) DK0732935T3 (da)
ES (1) ES2123951T3 (da)
HK (1) HK1008815A1 (da)
IL (1) IL112088A (da)
NZ (1) NZ278252A (da)
WO (1) WO1995017206A1 (da)
ZA (1) ZA9410189B (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
GB9515839D0 (en) * 1995-08-02 1995-10-04 Q One Biotech Ltd Feline stem cell factor
TWI240627B (en) * 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
US6017876A (en) 1997-08-15 2000-01-25 Amgen Inc. Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity
US6541033B1 (en) 1998-06-30 2003-04-01 Amgen Inc. Thermosensitive biodegradable hydrogels for sustained delivery of leptin
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
US6500418B1 (en) * 1999-02-12 2002-12-31 The Washington University Stimulating neutrophil function to treat inflammatory bowel disease
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US6472208B1 (en) * 1999-12-13 2002-10-29 Héma-Québec Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
EP2322601A1 (en) 2000-12-06 2011-05-18 Anthrogenesis Corporation Method of collecting placental stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
CA2438153C (en) * 2001-02-14 2015-06-02 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US7682803B2 (en) 2005-10-13 2010-03-23 Anthrogenesis Corporation Immunomodulation using placental stem cells
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
JP3963786B2 (ja) * 2002-06-11 2007-08-22 富士通株式会社 情報処理装置
KR20050086780A (ko) 2002-11-26 2005-08-30 안트로제네시스 코포레이션 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
EP1601248A4 (en) * 2003-02-13 2010-01-27 Anthrogenesis Corp USE OF UMBILICAL CORD BLOOD FOR TREATING INDIVIDUALS WITH DISEASE, DISORDER OR PATHOLOGY
GB0321337D0 (en) * 2003-09-11 2003-10-15 Massone Mobile Advertising Sys Method and system for distributing advertisements
EP1694328A4 (en) * 2003-12-02 2010-02-17 Celgene Corp METHOD AND COMPOSITIONS FOR THE TREATMENT AND SUPPLY OF HEMOGLOBINOPATHY AND ANEMIA
CA2552241C (en) 2003-12-30 2013-10-01 Durect Corporation Co-polymeric devices for controlled release of active agents
EP1909831A4 (en) 2005-06-14 2013-02-20 Amgen Inc PREPARATIONS OF SPONTANEOUS TAMPING PROTEINS
AU2006275475A1 (en) * 2005-07-29 2007-02-08 Amgen Inc. Formulations that inhibit protein aggregation
CN101395266B (zh) 2005-12-29 2018-06-15 人类起源公司 胎盘干细胞群
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
AR059066A1 (es) 2006-01-27 2008-03-12 Amgen Inc Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
EP1854478A1 (en) * 2006-05-12 2007-11-14 Cytos Biotechnology AG Nicotine-carrier vaccine formulation
CN101631852A (zh) 2006-10-23 2010-01-20 人类起源公司 用胎盘细胞群治疗骨缺损的方法和组合物
EP2630959A1 (en) 2007-02-12 2013-08-28 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
US20100172830A1 (en) * 2007-03-29 2010-07-08 Cellx Inc. Extraembryonic Tissue cells and method of use thereof
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
RU2010116271A (ru) * 2007-09-26 2011-11-10 Селджин Селльюлар Терапьютикс (Us) Ангиогенные клетки из плацентарного перфузата человека
KR20210127819A (ko) * 2007-09-28 2021-10-22 안트로제네시스 코포레이션 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
KR20220098055A (ko) * 2007-11-07 2022-07-08 셀룰래리티 인코포레이티드 조산 합병증의 치료에 있어서의 제대혈의 용도
RU2558778C2 (ru) * 2008-08-20 2015-08-10 Антродженезис Корпорейшн Лечение инсульта с использованием изолированных плацентарных клеток
KR20210010648A (ko) * 2008-08-20 2021-01-27 안트로제네시스 코포레이션 개선된 세포 조성물 및 그의 제조 방법
EP2331109B1 (en) * 2008-08-22 2013-05-29 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
EP2367932B1 (en) 2008-11-19 2019-06-12 Celularity, Inc. Amnion derived adherent cells
NZ592839A (en) * 2008-11-21 2012-10-26 Anthrogenesis Corp Treatment of diseases, disorders or conditions of the lung using placental cells
CA2767014C (en) 2009-07-02 2022-01-25 Anthrogenesis Corporation Method of producing erythrocytes without feeder cells
WO2011094181A1 (en) * 2010-01-26 2011-08-04 Anthrogenesis Corporation Treatment of bone-related cancers using placental stem cells
CN107699541A (zh) 2010-04-07 2018-02-16 人类起源公司 使用胎盘干细胞的血管生成
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
KR20200077613A (ko) 2010-07-13 2020-06-30 안트로제네시스 코포레이션 천연 킬러 세포의 생성 방법
PT2621519T (pt) 2010-09-28 2017-10-04 Aegerion Pharmaceuticals Inc Polipéptido de fusão de leptina-abd com duração de ação melhorada
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
ES2707579T3 (es) 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
JP2016506968A (ja) 2013-02-05 2016-03-07 アントフロゲネシス コーポレーション 胎盤由来のナチュラルキラー細胞
EP3334747B1 (en) 2015-08-13 2023-09-27 Amgen Inc. Charged depth filtration of antigen-binding proteins

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165370A (en) 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
JPS5534001A (en) * 1978-08-28 1980-03-10 Noda Sangyo Kagaku Kenkyusho Stabilization of sarcosine oxidase
US4783441A (en) 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
EP0035204B2 (en) 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
JPS5874617A (ja) 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
JPS58134991A (ja) * 1981-12-28 1983-08-11 Takeda Chem Ind Ltd セラチオペプチタ−ゼの安定化法
JPS59134730A (ja) 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
FI86885C (fi) 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
SE8501050D0 (sv) 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
CA1292686C (en) 1986-10-27 1991-12-03 Ze'ev Shaked Pharmaceutical compositions of recombinant interleukin-2 and formulation process
NZ226170A (en) 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
CA1329760C (en) * 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media
US4877608A (en) 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
US5096885A (en) 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
ATE108326T1 (de) 1989-01-30 1994-07-15 Corint Ltd Wässerige desmopressin-cmc enthaltende arzneizubereitung.
JPH02268681A (ja) * 1989-04-07 1990-11-02 Green Cross Corp:The ウロキナーゼ前駆体の安定化方法及び乾燥製剤
JPH03505334A (ja) * 1989-04-11 1991-11-21 イミユノバイオロジー・リサーチ・インスチチユート・インコーポレーテツド 凍結乾燥されたペプチド製剤
HU220234B (hu) 1989-10-16 2001-11-28 Amgen Inc. Eljárás stem sejtek működését befolyásoló faktorok előállitására
EP1241258A3 (en) 1989-10-16 2003-12-10 Amgen Inc. Stem cell factor
SE465222C5 (sv) 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
DE4001451A1 (de) 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
EP0536317A1 (en) 1990-06-25 1993-04-14 Immunex Corporation Mast cell growth factor
UA41502C2 (uk) * 1991-12-20 2001-09-17 Ново Нордіск А/С Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
US5192743A (en) 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
WO1994007510A1 (en) * 1992-10-02 1994-04-14 Kabi Pharmacia Ab Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer

Also Published As

Publication number Publication date
CN1142771A (zh) 1997-02-12
US6020469A (en) 2000-02-01
US5965522A (en) 1999-10-12
WO1995017206A1 (en) 1995-06-29
IL112088A0 (en) 1995-03-15
US20020013258A1 (en) 2002-01-31
DK0732935T3 (da) 1999-08-02
ATE173402T1 (de) 1998-12-15
EP0732935A1 (en) 1996-09-25
HK1008815A1 (en) 1999-05-21
CA2182970C (en) 2000-11-28
US6288030B1 (en) 2001-09-11
ES2123951T3 (es) 1999-01-16
AU696860B2 (en) 1998-09-17
DE69414723D1 (de) 1998-12-24
EP0732935B1 (en) 1998-11-18
CN1105575C (zh) 2003-04-16
DE69414723T2 (de) 1999-07-22
NZ278252A (en) 1998-04-27
CA2182970A1 (en) 1995-06-29
AU1442295A (en) 1995-07-10
IL112088A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
ZA9410189B (en) Novel stem cell factor formulations and methods
IL113578A0 (en) Stable freeze-dried formulation comprising a protein
WO1995013297A3 (en) Improved immunogenic compositions against human gastrin 17
CA2191213A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
DE3586697D1 (en) Aktive thymopentin-analoga.
EP0182372A3 (en) New factor viii coagulant polypeptides
AU5327386A (en) Peptide derivatives, analogous to pepstatin, which inhibit renin and acid proteases.
KR0180256B1 (en) Bpc peptides, their preparation and use
AR244544A1 (es) Composicion desodorante.
AU6645294A (en) L-amino acid oxidase
MX9708426A (es) Polipeptido hk2 de variante estable.
IE873239L (en) Variants of hirudin
PH31320A (en) Fenbendazole formulations.
AU1384995A (en) Human circulating cytokine cc-1
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
GR3031122T3 (en) Stable lyophilized thiotepa composition.
NZ326769A (en) High-content famciclovir tablets
AU1518688A (en) Stable creatine amidinohydrolase mutants
EP0219716A3 (en) Immunosuppressive agent
MX9705959A (es) Formulaciones para il-12.
AU3573193A (en) Recombinant plant enzyme